Insider · CIK 0001340097

Invus Public Equities, L.P.

Reports to the SEC for 9 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001340097

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-12-10	SRRKScholar Rock Holding CorpS Sale	10% Owner	SSale	−1.6M sh	$41.65	−$66.6M	9,250,005
2024-11-25	SRRKScholar Rock Holding CorpS Sale	10% Owner	SSale	−208K sh	$37.63	−$7.84M	11,051,166
2024-11-25	SRRKScholar Rock Holding CorpS Sale	10% Owner	SSale	−43.9K sh	$38.43	−$1.69M	11,007,279
2024-11-25	SRRKScholar Rock Holding CorpS Sale	10% Owner	SSale	−126K sh	$39.51	−$5M	10,880,837
2024-11-25	SRRKScholar Rock Holding CorpS Sale	10% Owner	SSale	−30.7K sh	$40.14	−$1.23M	10,850,154
2024-11-25	SRRKScholar Rock Holding CorpS Sale	10% Owner	SSale	−149 sh	$40.98	−$6,106.02	10,850,005
2024-08-08	CBIOCRESCENT BIOPHARMA, INC.S Sale	10% Owner	SSale	−261K sh	$0.19	−$50K	6,317,565
2024-08-07	CBIOCRESCENT BIOPHARMA, INC.S Sale	10% Owner	SSale	−61.5K sh	$0.18	−$11.2K	6,578,438
2024-08-06	CBIOCRESCENT BIOPHARMA, INC.S Sale	10% Owner	SSale	−55.7K sh	$0.18	−$10.2K	6,639,926
2024-08-05	CBIOCRESCENT BIOPHARMA, INC.S Sale	10% Owner	SSale	−165K sh	$0.19	−$31K	6,695,658
2024-08-02	CBIOCRESCENT BIOPHARMA, INC.S Sale	10% Owner	SSale	−286K sh	$0.20	−$57.4K	6,860,181
2024-08-01	CBIOCRESCENT BIOPHARMA, INC.S Sale	10% Owner	SSale	−63.6K sh	$0.22	−$13.7K	7,146,381
2024-07-30	CBIOCRESCENT BIOPHARMA, INC.S Sale	10% Owner	SSale	−757K sh	$0.22	−$167K	7,209,945
2024-07-29	CBIOCRESCENT BIOPHARMA, INC.S Sale	10% Owner	SSale	−364K sh	$0.24	−$85.6K	7,966,780
2024-07-26	CBIOCRESCENT BIOPHARMA, INC.S Sale	10% Owner	SSale	−258K sh	$0.24	−$62.4K	8,330,729
2023-10-12	SRRKScholar Rock Holding CorpP Purchase	10% Owner	PPurchase	+2.19M sh	$6.85	+$15M	11,249,288
2023-10-12	SRRKScholar Rock Holding CorpP Purchase	10% Owner	PPurchase	+10.2K sh	$8.55	+$86.7K	11,259,438
2023-04-28	SRRKScholar Rock Holding CorpP Purchase	10% Owner	PPurchase	+31.6K sh	$6.43	+$203K	9,059,507
2023-02-24	CBIOCRESCENT BIOPHARMA, INC.P Purchase	10% Owner	PPurchase	+100K sh	$1.70	+$170K	8,589,064
2023-02-23	CBIOCRESCENT BIOPHARMA, INC.P Purchase	10% Owner	PPurchase	+200K sh	$1.75	+$351K	8,489,064
2023-02-22	CBIOCRESCENT BIOPHARMA, INC.P Purchase	10% Owner	PPurchase	+150K sh	$1.79	+$269K	8,289,064
2023-02-21	CBIOCRESCENT BIOPHARMA, INC.P Purchase	10% Owner	PPurchase	+50K sh	$1.85	+$92.5K	8,139,064
2023-02-17	CBIOCRESCENT BIOPHARMA, INC.P Purchase	10% Owner	PPurchase	+200K sh	$1.71	+$341K	8,089,064
2023-02-16	CBIOCRESCENT BIOPHARMA, INC.P Purchase	10% Owner	PPurchase	+315K sh	$1.68	+$531K	7,889,064
2023-02-15	CBIOCRESCENT BIOPHARMA, INC.P Purchase	10% Owner	PPurchase	+1M sh	$2.16	+$2.16M	7,573,798
2023-02-09	CBIOCRESCENT BIOPHARMA, INC.P Purchase	10% Owner	PPurchase	+11.5K sh	$3.24	+$37.1K	6,573,798
2023-01-09	SRRKScholar Rock Holding CorpS Sale	10% Owner	SSale	−1,094 sh	$9.48	−$10.4K	9,027,950
2023-01-05	SRRKScholar Rock Holding CorpP Purchase	10% Owner	PPurchase	+48.8K sh	$9.33	+$455K	9,029,044
2022-10-25	SRRKScholar Rock Holding CorpP Purchase	10% Owner	PPurchase	+130K sh	$8.04	+$1.05M	8,980,270
2022-10-04	SRRKScholar Rock Holding CorpP Purchase	10% Owner	PPurchase	+66K sh	$7.89	+$521K	8,850,005
2022-10-03	SRRKScholar Rock Holding CorpP Purchase	10% Owner	PPurchase	+34K sh	$7.03	+$239K	8,784,005
2021-08-03	Omega Therapeutics, Inc.C Conversion	10% Owner	CConversion	+1.32M sh	—	—	1,398,530
2021-08-03	Omega Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+875K sh	$17.00	+$14.9M	2,273,530
2021-08-03	Omega Therapeutics, Inc.Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−5M sh	—	—	0
2021-07-30	Omega Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+75K sh	$16.14	+$1.21M	75,000
2021-02-01	SEERSeer, Inc.S Sale	10% Owner	SSale	−253K sh	$64.15	−$16.2M	5,588,366
2020-12-16	LXRXLEXICON PHARMACEUTICALS, INC.P Purchase	Director, 10% Owner	PPurchase	+10.9M sh	$3.20	+$35M	32,259,461
2020-12-08	SEERSeer, Inc.C Conversion	10% Owner	CConversion	+5.05M sh	—	—	5,050,911
2020-12-08	SEERSeer, Inc.P Purchase	10% Owner	PPurchase	+790K sh	$19.00	+$15M	5,840,911
2020-12-08	SEERSeer, Inc. · Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−3.95M sh	—	—	0
2020-12-08	SEERSeer, Inc. · Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−374K sh	—	—	0
2020-12-08	SEERSeer, Inc. · Series D Convertible Preferred StockC Conversion	10% Owner	CConversion	−474K sh	—	—	0
2020-12-08	SEERSeer, Inc. · Series D-1 Convertible Preferred StockC Conversion	10% Owner	CConversion	−249K sh	—	—	0
2020-11-03	SQZ Biotechnologies CoC Conversion	10% Owner	CConversion	+1.14M sh	—	—	1,141,308
2020-11-03	SQZ Biotechnologies CoP Purchase	10% Owner	PPurchase	+465K sh	$16.00	+$7.44M	1,606,308
2020-11-03	SQZ Biotechnologies CoSeries C Convertible Preferred StockC Conversion	10% Owner	CConversion	−843K sh	—	—	0
2020-11-03	SQZ Biotechnologies CoSeries D Convertible Preferred StockC Conversion	10% Owner	CConversion	−240K sh	—	—	0
2020-06-16	GBIOGeneration Bio Co.C Conversion	10% Owner	CConversion	+2.01M sh	—	—	2,014,191
2020-06-16	GBIOGeneration Bio Co.P Purchase	10% Owner	PPurchase	+800K sh	$19.00	+$15.2M	2,814,191
2020-06-16	GBIOGeneration Bio Co. · Series B Preferred StockC Conversion	10% Owner	CConversion	−2.19M sh	—	—	0

Recent filings

Accepted (ET)
Dec 124
DEBBANE RAYMOND0000950170-24-135847
SEC(opens sec.gov)
Nov 274
DEBBANE RAYMOND0000950170-24-131539
SEC(opens sec.gov)
Aug 94
DEBBANE RAYMOND0000950170-24-094800
SEC(opens sec.gov)
Aug 74
DEBBANE RAYMOND0000950170-24-092864
SEC(opens sec.gov)
Aug 54
DEBBANE RAYMOND0000950170-24-090910
SEC(opens sec.gov)
Jul 304
DEBBANE RAYMOND0000950170-24-088020
SEC(opens sec.gov)
Oct 164
Artal Group S.A.0000950170-23-053600
SEC(opens sec.gov)
May 24
Artal Group S.A.0000899243-23-012043
SEC(opens sec.gov)
Feb 284
Artal Group S.A.0000899243-23-006426
SEC(opens sec.gov)
Feb 234
Artal Group S.A.0000899243-23-006027
SEC(opens sec.gov)

Companies

Address

750 LEXINGTON AVENUE 30TH FLOOR

NEW YORK, NY, 10022